$VCEL
Vericel Corporation
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$40.05
▼-1.69%-$0.690
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateVericel Corporation
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is VCEL down today? It is at $40.05 (-1.69%), and our scanner flagged it 53 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VCEL spikes, and full due diligence on VCEL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VCEL 53 times in the last 30 days. Create a free account to track $VCEL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on VCEL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VCEL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystVericel Corp: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Aug 14, 2026 · 55 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Mclaughlin Kevin F Director | Sold (automatic/other) | -7K 0.01% of company | sold 28% | 18K | $312K at $44.53 | Aug 12, 26 |
Mclaughlin Kevin F Director | Other | 7K 0.01% of company | added 38% | 25K | $91K at $13.05 | Aug 12, 26 |
Halpin Michael Officer | Sold (automatic/other) | -10K 0.02% of company | sold 38% | 16K | $468K at $46.84 | Aug 3, 26 |
Halpin Michael Officer | Other | 10K 0.02% of company | added 61% | 26K | $167K at $16.66 | Aug 3, 26 |
Siegal Jonathan Officer | Sold (automatic/other) | -5K | sold 81% | 1K | $220K at $48.90 | Jul 30, 26 |
Siegal Jonathan Officer | Other | 5K | n/a | 4K | $134K at $29.82 | Jul 30, 26 |
Hopper Jonathan Mark Officer | Sold (automatic/other) | -10K 0.02% of company | sold 12% | 76K | $450K at $45.00 | Jun 26, 26 |
Hopper Jonathan Mark Officer | Other | 10K 0.02% of company | added 14% | 81K | $298K at $29.82 | Jun 26, 26 |
Mara Joseph Anthony Jr Officer | Sold (automatic/other) | -5K | sold 24% | 16K | $224K at $44.75 | Jun 26, 26 |
Flynn Sean C. Officer | Sold (automatic/other) | -15K 0.03% of company | sold 90% | 2K | $685K at $45.64 | Jun 26, 26 |
Flynn Sean C. Officer | Other | 15K 0.03% of company | added 100% | 17K | $244K at $16.25 | Jun 26, 26 |
Siegal Jonathan Officer | Sold (automatic/other) | -3K | sold 76% | 886 | $123K at $44.90 | Jun 26, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on VCEL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for VCEL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
VCEL last traded at $40.05, down 1.69% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Vericel Corporation (VCEL) is next expected to report earnings on Thursday, November 5, 2026, about 27 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VCEL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VCEL 53 times in the last 30 days.
VCEL (Vericel Corporation) trades on XNAS, with a market cap of about $2.05B in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VCEL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VCEL discussion
Sign in to ask a question or join the discussion.